Nuzenio

Oculis Holding

Oculis Holding news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Oculis signs asset deal with Accure Therapeutics for privosegtor - thepharmaletter.comthepharmaletter.com · Mon, 10 Aug 2026 12:33:45 GMTOculis Holding (OCS) inks $3.8M cash-plus-shares deal for Privosegtor rights - Stock TitanStock Titan · Mon, 10 Aug 2026 12:00:34 GMTOculis to Buy Accure's Global Development, Commercial Rights to Privosegtor - marketscreener.commarketscreener.com · Mon, 10 Aug 2026 08:58:41 GMTOculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 07:30:00 GMTOculis acquires full rights to Privosegtor, boo... - PluangPluang · Mon, 10 Aug 2026 07:26:37 GMTOCS Stock Drops Over 23% — Eye Drop Trial For Diabetic Vision Loss Misses Target - StocktwitsStocktwits · Fri, 07 Aug 2026 22:15:02 GMTOculis Holding AG (OCS) Stock News Today - TradingKeyTradingKey · Fri, 07 Aug 2026 12:42:30 GMTOculis Holding AG Stock 12‑Month Price Target Cut to $36.26, Implies 193% Upside - TradingViewTradingView · Fri, 07 Aug 2026 06:20:00 GMT

Timeline

Mon, 10 Aug 2026 12:33:45 GMTOculis signs asset deal with Accure Therapeutics for privosegtor - thepharmaletter.com
Mon, 10 Aug 2026 12:00:34 GMTOculis Holding (OCS) inks $3.8M cash-plus-shares deal for Privosegtor rights - Stock Titan
Mon, 10 Aug 2026 08:58:41 GMTOculis to Buy Accure's Global Development, Commercial Rights to Privosegtor - marketscreener.com
Mon, 10 Aug 2026 07:30:00 GMTOculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company - Yahoo Finance
Mon, 10 Aug 2026 07:26:37 GMTOculis acquires full rights to Privosegtor, boo... - Pluang
Fri, 07 Aug 2026 22:15:02 GMTOCS Stock Drops Over 23% — Eye Drop Trial For Diabetic Vision Loss Misses Target - Stocktwits

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Oculis Holding.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.